Adaptate Biotherapeutics

Adaptate Biotherapeutics is a biotherapeutics company based in London, founded in 2019 by Adrian Hayday. The company specializes in developing antibody-based therapies aimed at modulating gamma delta T cells in situ. By leveraging innovative technology, Adaptate focuses on creating immunotherapies that target cancer and autoimmune diseases. The company's work holds the promise of significantly enhancing treatment options for patients, providing effective medical solutions for various immune-related conditions.